APO Research
Talk to an analyst

APO RESEARCH · REPORT

Velcade

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Velcade Industry Growth and Trends Forecast to 2032

29 December 2025109 pages

Choose your research edition.

Industry ResearchVelcade Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Velcade Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Velcade Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Velcade Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Velcade Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Velcade market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Velcade include Ben Venue Laboratories, Hospira, Beijing Shuanglu Pharmaceutical, Guangdong Lingnan Pharmaceutical, Sinopharm Pharmaceutical, Harbin Sanlian Pharmaceutical, XISUN, Nanjing Zhengda Tianqing Pharmaceutical and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Velcade market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Velcade market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Velcade market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Velcade.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Velcade market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Velcade Market by Company

Ben Venue Laboratories

Hospira

Beijing Shuanglu Pharmaceutical

Guangdong Lingnan Pharmaceutical

Sinopharm Pharmaceutical

Harbin Sanlian Pharmaceutical

XISUN

Nanjing Zhengda Tianqing Pharmaceutical

Johnson & Johnson

Shandong Luoxin Pharmaceutical Group

Shanxi Pude Pharmaceutical

Wuhan Renfu Pharmaceutical

Takeda

Xi'an Yangsen Pharmaceutical

Velcade Segment by Type

1.0 Mg Injection

3.5 Mg Injection

Velcade Segment by Application

Multiple Myeloma

Mantle Cell Lymphoma

Velcade Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Velcade market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Velcade and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Velcade.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Velcade manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Velcade in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1.0 Mg Injection Table 2. Major Company of 3.5 Mg Injection Table 3. Global Velcade Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Velcade Sales by Type (2021-2026) & (K Units) Table 5. Global Velcade Sales Market Share in Volume by Type (2021-2026) Table 6. Global Velcade Sales by Type (2021-2026) & (US$ Million) Table 7. Global Velcade Sales Market Share in Value by Type (2021-2026) Table 8. Global Velcade Price by Type (2021-2026) & (US$/Unit) Table 9. Global Velcade Sales by Type (2027-2032) & (K Units) Table 10. Global Velcade Sales Market Share in Volume by Type (2027-2032) Table 11. Global Velcade Sales by Type (2027-2032) & (US$ Million) Table 12. Global Velcade Sales Market Share in Value by Type (2027-2032) Table 13. Global Velcade Price by Type (2027-2032) & (US$/Unit) Table 14. North America Velcade Sales by Type (2021-2026) & (K Units) Table 15. North America Velcade Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Velcade Sales by Type (2021-2026) & (K Units) Table 17. Europe Velcade Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Velcade Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Velcade Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Velcade Sales by Type (2021-2026) & (K Units) Table 21. Latin America Velcade Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Velcade Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Velcade Sales by Type (2021-2026) & (US$ Million) Table 24. Velcade Industry Trends Table 25. Velcade Industry Drivers Table 26. Velcade Industry Opportunities and Challenges Table 27. Velcade Industry Restraints Table 28. Global Velcade Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Velcade Revenue Market Share by Company (2021-2026) Table 30. Global Velcade Sales by Company (2021-2026) & (K Units) Table 31. Global Velcade Sales Share by Company (2021-2026) Table 32. Global Velcade Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Velcade Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Velcade Major Company Production Sites and Headquarters Table 35. Global Velcade Company, Product Type & Application Table 36. Global Velcade Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Velcade by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Velcade Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Velcade Sales by Region (2021-2026) & (K Units) Table 41. Global Velcade Sales Market Share in Volume by Region (2021-2026) Table 42. Global Velcade Sales by Region (2021-2026) & (US$ Million) Table 43. Global Velcade Sales Market Share in Value by Region (2021-2026) Table 44. Global Velcade Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Velcade Sales by Region (2027-2032) & (K Units) Table 46. Global Velcade Sales Market Share in Volume by Region (2027-2032) Table 47. Global Velcade Sales by Region (2027-2032) & (US$ Million) Table 48. Global Velcade Sales Market Share in Value by Region (2027-2032) Table 49. Global Velcade Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Velcade Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Velcade Sales by Application (2021-2026) & (K Units) Table 52. Global Velcade Sales Market Share in Volume by Application (2021-2026) Table 53. Global Velcade Sales by Application (2021-2026) & (US$ Million) Table 54. Global Velcade Sales Market Share in Value by Application (2021-2026) Table 55. Global Velcade Price by Application (2021-2026) & (US$/Unit) Table 56. Global Velcade Sales by Application (2027-2032) & (K Units) Table 57. Global Velcade Sales Market Share in Volume by Application (2027-2032) Table 58. Global Velcade Sales by Application (2027-2032) & (US$ Million) Table 59. Global Velcade Sales Market Share in Value by Application (2027-2032) Table 60. Global Velcade Price by Application (2027-2032) & (US$/Unit) Table 61. North America Velcade Sales by Application (2021-2026) & (K Units) Table 62. North America Velcade Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Velcade Sales by Application (2021-2026) & (K Units) Table 64. Europe Velcade Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Velcade Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Velcade Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Velcade Sales by Application (2021-2026) & (K Units) Table 68. Latin America Velcade Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Velcade Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Velcade Sales by Application (2021-2026) & (US$ Million) Table 71. Ben Venue Laboratories Company Information Table 72. Ben Venue Laboratories Business Overview Table 73. Ben Venue Laboratories Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Ben Venue Laboratories Velcade Product Portfolio Table 75. Ben Venue Laboratories Recent Development Table 76. Hospira Company Information Table 77. Hospira Business Overview Table 78. Hospira Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hospira Velcade Product Portfolio Table 80. Hospira Recent Development Table 81. Beijing Shuanglu Pharmaceutical Company Information Table 82. Beijing Shuanglu Pharmaceutical Business Overview Table 83. Beijing Shuanglu Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Beijing Shuanglu Pharmaceutical Velcade Product Portfolio Table 85. Beijing Shuanglu Pharmaceutical Recent Development Table 86. Guangdong Lingnan Pharmaceutical Company Information Table 87. Guangdong Lingnan Pharmaceutical Business Overview Table 88. Guangdong Lingnan Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Guangdong Lingnan Pharmaceutical Velcade Product Portfolio Table 90. Guangdong Lingnan Pharmaceutical Recent Development Table 91. Sinopharm Pharmaceutical Company Information Table 92. Sinopharm Pharmaceutical Business Overview Table 93. Sinopharm Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sinopharm Pharmaceutical Velcade Product Portfolio Table 95. Sinopharm Pharmaceutical Recent Development Table 96. Harbin Sanlian Pharmaceutical Company Information Table 97. Harbin Sanlian Pharmaceutical Business Overview Table 98. Harbin Sanlian Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Harbin Sanlian Pharmaceutical Velcade Product Portfolio Table 100. Harbin Sanlian Pharmaceutical Recent Development Table 101. XISUN Company Information Table 102. XISUN Business Overview Table 103. XISUN Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. XISUN Velcade Product Portfolio Table 105. XISUN Recent Development Table 106. Nanjing Zhengda Tianqing Pharmaceutical Company Information Table 107. Nanjing Zhengda Tianqing Pharmaceutical Business Overview Table 108. Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Nanjing Zhengda Tianqing Pharmaceutical Velcade Product Portfolio Table 110. Nanjing Zhengda Tianqing Pharmaceutical Recent Development Table 111. Johnson & Johnson Company Information Table 112. Johnson & Johnson Business Overview Table 113. Johnson & Johnson Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Johnson & Johnson Velcade Product Portfolio Table 115. Johnson & Johnson Recent Development Table 116. Shandong Luoxin Pharmaceutical Group Company Information Table 117. Shandong Luoxin Pharmaceutical Group Business Overview Table 118. Shandong Luoxin Pharmaceutical Group Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shandong Luoxin Pharmaceutical Group Velcade Product Portfolio Table 120. Shandong Luoxin Pharmaceutical Group Recent Development Table 121. Shanxi Pude Pharmaceutical Company Information Table 122. Shanxi Pude Pharmaceutical Business Overview Table 123. Shanxi Pude Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Shanxi Pude Pharmaceutical Velcade Product Portfolio Table 125. Shanxi Pude Pharmaceutical Recent Development Table 126. Wuhan Renfu Pharmaceutical Company Information Table 127. Wuhan Renfu Pharmaceutical Business Overview Table 128. Wuhan Renfu Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Wuhan Renfu Pharmaceutical Velcade Product Portfolio Table 130. Wuhan Renfu Pharmaceutical Recent Development Table 131. Takeda Company Information Table 132. Takeda Business Overview Table 133. Takeda Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Takeda Velcade Product Portfolio Table 135. Takeda Recent Development Table 136. Xi'an Yangsen Pharmaceutical Company Information Table 137. Xi'an Yangsen Pharmaceutical Business Overview Table 138. Xi'an Yangsen Pharmaceutical Velcade Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Xi'an Yangsen Pharmaceutical Velcade Product Portfolio Table 140. Xi'an Yangsen Pharmaceutical Recent Development Table 141. North America Velcade Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Velcade Sales by Country (2021-2026) & (K Units) Table 143. North America Velcade Sales Market Share by Country (2021-2026) Table 144. North America Velcade Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Velcade Sales Market Share Forecast by Country (2027-2032) Table 146. North America Velcade Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Velcade Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Velcade Market Share by Country (2021-2026) Table 149. North America Velcade Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Velcade Market Share Forecast by Country (2027-2032) Table 151. Europe Velcade Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Velcade Sales by Country (2021-2026) & (K Units) Table 153. Europe Velcade Sales Market Share by Country (2021-2026) Table 154. Europe Velcade Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Velcade Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Velcade Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Velcade Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Velcade Market Share by Country (2021-2026) Table 159. Europe Velcade Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Velcade Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Velcade Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Velcade Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Velcade Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Velcade Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Velcade Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Velcade Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Velcade Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Velcade Market Share by Country (2021-2026) Table 169. Asia-Pacific Velcade Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Velcade Market Share Forecast by Country (2027-2032) Table 171. Latin America Velcade Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Velcade Sales by Country (2021-2026) & (K Units) Table 173. Latin America Velcade Sales Market Share by Country (2021-2026) Table 174. Latin America Velcade Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Velcade Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Velcade Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Velcade Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Velcade Market Share by Country (2021-2026) Table 179. Latin America Velcade Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Velcade Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Velcade Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Velcade Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Velcade Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Velcade Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Velcade Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Velcade Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Velcade Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Velcade Market Share by Country (2021-2026) Table 189. Middle East and Africa Velcade Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Velcade Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Velcade Distributors List Table 194. Velcade Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Velcade Image Figure 2. Global Velcade Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Velcade Market Size (2021-2032) & (US$ Million) Figure 4. Global Velcade Sales (2021-2032) & (K Units) Figure 5. 1.0 Mg Injection Image Figure 6. Global 1.0 Mg Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. 3.5 Mg Injection Image Figure 8. Global 3.5 Mg Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Velcade Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Velcade Market Share by Type 2025 VS 2032 Figure 11. North America Velcade Sales Market Share in Volume by Type in 2025 Figure 12. North America Velcade Sales Market Share in Value by Type in 2025 Figure 13. Europe Velcade Sales Market Share in Volume by Type in 2025 Figure 14. Europe Velcade Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Velcade Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Velcade Sales Market Share in Value by Type in 2025 Figure 17. Latin America Velcade Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Velcade Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Velcade Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Velcade Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Velcade Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Multiple Myeloma Image Figure 24. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (K Units) Figure 25. Mantle Cell Lymphoma Image Figure 26. Global Mantle Cell Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Velcade Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Velcade Market Share by Application 2025 VS 2032 Figure 29. North America Velcade Sales Market Share in Volume by Application in 2025 Figure 30. North America Velcade Sales Market Share in Value by Application in 2025 Figure 31. Europe Velcade Sales Market Share in Volume by Application in 2025 Figure 32. Europe Velcade Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Velcade Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Velcade Sales Market Share in Value by Application in 2025 Figure 35. Latin America Velcade Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Velcade Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Velcade Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Velcade Sales Market Share in Value by Application in 2025 Figure 39. North America Velcade Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Velcade Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Velcade Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Velcade Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Velcade Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Velcade Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Velcade Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Velcade Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Velcade Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Velcade Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Velcade Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Velcade Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Velcade Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Velcade Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Velcade Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Velcade Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Velcade Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Velcade Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Velcade Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Velcade Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Velcade Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Velcade Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 1.0 Mg Injection
  • 3.5 Mg Injection
Applications
  • Multiple Myeloma
  • Mantle Cell Lymphoma
Companies covered
  • Ben Venue Laboratories
  • Hospira
  • Beijing Shuanglu Pharmaceutical
  • Guangdong Lingnan Pharmaceutical
  • Sinopharm Pharmaceutical
  • Harbin Sanlian Pharmaceutical
  • XISUN
  • Nanjing Zhengda Tianqing Pharmaceutical
  • Johnson & Johnson
  • Shandong Luoxin Pharmaceutical Group
  • Shanxi Pude Pharmaceutical
  • Wuhan Renfu Pharmaceutical
  • Takeda
  • Xi'an Yangsen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Velcade Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Velcade Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Velcade Market by Type
  6. 1.3.1 1.0 Mg Injection
  7. 1.3.2 3.5 Mg Injection
  8. 1.4 Global Velcade Market Size by Type
  9. 1.4.1 Global Velcade Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Velcade Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Velcade Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Velcade Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Velcade Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Velcade Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Velcade Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Velcade Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Velcade Industry Trends
  2. 2.2 Velcade Industry Drivers
  3. 2.3 Velcade Industry Opportunities and Challenges
  4. 2.4 Velcade Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Velcade Revenue (2021-2026)
  2. 3.2 Global Top Players by Velcade Sales (2021-2026)
  3. 3.3 Global Top Players by Velcade Price (2021-2026)
  4. 3.4 Global Velcade Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Velcade Major Company Production Sites & Headquarters
  6. 3.6 Global Velcade Company, Product Type & Application
  7. 3.7 Global Velcade Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Velcade Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Velcade Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Velcade Tier 1, Tier 2, and Tier 3
4 Velcade Regional Status and Outlook
  1. 4.1 Global Velcade Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Velcade Historic Market Size by Region
  3. 4.2.1 Global Velcade Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Velcade Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Velcade Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Velcade Forecasted Market Size by Region
  7. 4.3.1 Global Velcade Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Velcade Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Velcade Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Velcade by Application
  1. 5.1 Velcade Market by Application
  2. 5.1.1 Multiple Myeloma
  3. 5.1.2 Mantle Cell Lymphoma
  4. 5.2 Global Velcade Market Size by Application
  5. 5.2.1 Global Velcade Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Velcade Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Velcade Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Velcade Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Velcade Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Velcade Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Velcade Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Velcade Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ben Venue Laboratories
  2. 6.1.1 Ben Venue Laboratories Company Information
  3. 6.1.2 Ben Venue Laboratories Business Overview
  4. 6.1.3 Ben Venue Laboratories Velcade Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ben Venue Laboratories Velcade Product Portfolio
  6. 6.1.5 Ben Venue Laboratories Recent Developments
  7. 6.2 Hospira
  8. 6.2.1 Hospira Company Information
  9. 6.2.2 Hospira Business Overview
  10. 6.2.3 Hospira Velcade Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hospira Velcade Product Portfolio
  12. 6.2.5 Hospira Recent Developments
  13. 6.3 Beijing Shuanglu Pharmaceutical
  14. 6.3.1 Beijing Shuanglu Pharmaceutical Company Information
  15. 6.3.2 Beijing Shuanglu Pharmaceutical Business Overview
  16. 6.3.3 Beijing Shuanglu Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Beijing Shuanglu Pharmaceutical Velcade Product Portfolio
  18. 6.3.5 Beijing Shuanglu Pharmaceutical Recent Developments
  19. 6.4 Guangdong Lingnan Pharmaceutical
  20. 6.4.1 Guangdong Lingnan Pharmaceutical Company Information
  21. 6.4.2 Guangdong Lingnan Pharmaceutical Business Overview
  22. 6.4.3 Guangdong Lingnan Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Guangdong Lingnan Pharmaceutical Velcade Product Portfolio
  24. 6.4.5 Guangdong Lingnan Pharmaceutical Recent Developments
  25. 6.5 Sinopharm Pharmaceutical
  26. 6.5.1 Sinopharm Pharmaceutical Company Information
  27. 6.5.2 Sinopharm Pharmaceutical Business Overview
  28. 6.5.3 Sinopharm Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinopharm Pharmaceutical Velcade Product Portfolio
  30. 6.5.5 Sinopharm Pharmaceutical Recent Developments
  31. 6.6 Harbin Sanlian Pharmaceutical
  32. 6.6.1 Harbin Sanlian Pharmaceutical Company Information
  33. 6.6.2 Harbin Sanlian Pharmaceutical Business Overview
  34. 6.6.3 Harbin Sanlian Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Harbin Sanlian Pharmaceutical Velcade Product Portfolio
  36. 6.6.5 Harbin Sanlian Pharmaceutical Recent Developments
  37. 6.7 XISUN
  38. 6.7.1 XISUN Company Information
  39. 6.7.2 XISUN Business Overview
  40. 6.7.3 XISUN Velcade Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 XISUN Velcade Product Portfolio
  42. 6.7.5 XISUN Recent Developments
  43. 6.8 Nanjing Zhengda Tianqing Pharmaceutical
  44. 6.8.1 Nanjing Zhengda Tianqing Pharmaceutical Company Information
  45. 6.8.2 Nanjing Zhengda Tianqing Pharmaceutical Business Overview
  46. 6.8.3 Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nanjing Zhengda Tianqing Pharmaceutical Velcade Product Portfolio
  48. 6.8.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Velcade Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Velcade Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Shandong Luoxin Pharmaceutical Group
  56. 6.10.1 Shandong Luoxin Pharmaceutical Group Company Information
  57. 6.10.2 Shandong Luoxin Pharmaceutical Group Business Overview
  58. 6.10.3 Shandong Luoxin Pharmaceutical Group Velcade Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shandong Luoxin Pharmaceutical Group Velcade Product Portfolio
  60. 6.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  61. 6.11 Shanxi Pude Pharmaceutical
  62. 6.11.1 Shanxi Pude Pharmaceutical Company Information
  63. 6.11.2 Shanxi Pude Pharmaceutical Business Overview
  64. 6.11.3 Shanxi Pude Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanxi Pude Pharmaceutical Velcade Product Portfolio
  66. 6.11.5 Shanxi Pude Pharmaceutical Recent Developments
  67. 6.12 Wuhan Renfu Pharmaceutical
  68. 6.12.1 Wuhan Renfu Pharmaceutical Company Information
  69. 6.12.2 Wuhan Renfu Pharmaceutical Business Overview
  70. 6.12.3 Wuhan Renfu Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Wuhan Renfu Pharmaceutical Velcade Product Portfolio
  72. 6.12.5 Wuhan Renfu Pharmaceutical Recent Developments
  73. 6.13 Takeda
  74. 6.13.1 Takeda Company Information
  75. 6.13.2 Takeda Business Overview
  76. 6.13.3 Takeda Velcade Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Velcade Product Portfolio
  78. 6.13.5 Takeda Recent Developments
  79. 6.14 Xi'an Yangsen Pharmaceutical
  80. 6.14.1 Xi'an Yangsen Pharmaceutical Company Information
  81. 6.14.2 Xi'an Yangsen Pharmaceutical Business Overview
  82. 6.14.3 Xi'an Yangsen Pharmaceutical Velcade Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Xi'an Yangsen Pharmaceutical Velcade Product Portfolio
  84. 6.14.5 Xi'an Yangsen Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Velcade Sales by Country
  2. 7.1.1 North America Velcade Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Velcade Sales by Country (2021-2026)
  4. 7.1.3 North America Velcade Sales Forecast by Country (2027-2032)
  5. 7.2 North America Velcade Market Size by Country
  6. 7.2.1 North America Velcade Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Velcade Market Size by Country (2021-2026)
  8. 7.2.3 North America Velcade Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Velcade Sales by Country
  2. 8.1.1 Europe Velcade Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Velcade Sales by Country (2021-2026)
  4. 8.1.3 Europe Velcade Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Velcade Market Size by Country
  6. 8.2.1 Europe Velcade Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Velcade Market Size by Country (2021-2026)
  8. 8.2.3 Europe Velcade Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Velcade Sales by Country
  2. 9.1.1 Asia-Pacific Velcade Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Velcade Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Velcade Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Velcade Market Size by Country
  6. 9.2.1 Asia-Pacific Velcade Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Velcade Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Velcade Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Velcade Sales by Country
  2. 10.1.1 South America Velcade Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Velcade Sales by Country (2021-2026)
  4. 10.1.3 South America Velcade Sales Forecast by Country (2027-2032)
  5. 10.2 South America Velcade Market Size by Country
  6. 10.2.1 South America Velcade Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Velcade Market Size by Country (2021-2026)
  8. 10.2.3 South America Velcade Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Velcade Sales by Country
  2. 11.1.1 Middle East and Africa Velcade Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Velcade Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Velcade Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Velcade Market Size by Country
  6. 11.2.1 Middle East and Africa Velcade Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Velcade Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Velcade Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Velcade Value Chain Analysis
  2. 12.1.1 Velcade Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Velcade Production Mode & Process
  7. 12.2 Velcade Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Velcade Distributors
  10. 12.2.3 Velcade Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst